Advertisement
Canada markets open in 2 hours 1 minute

  • S&P/TSX

    21,516.90
    -94.40 (-0.44%)
     

  • S&P 500

    5,487.03
    +13.80 (+0.25%)
     

  • DOW

    38,834.86
    +56.76 (+0.15%)
     

  • CAD/USD

    0.7295
    -0.0003 (-0.04%)
     

  • CRUDE OIL

    81.60
    +0.03 (+0.04%)
     

  • Bitcoin CAD

    90,982.46
    +1,371.80 (+1.53%)
     

  • CMC Crypto 200

    1,379.07
    -3.59 (-0.26%)
     

  • GOLD FUTURES

    2,353.10
    +6.20 (+0.26%)
     

  • RUSSELL 2000

    2,025.23
    +3.22 (+0.16%)
     

  • 10-Yr Bond

    4.2170
    0.0000 (0.00%)
     

  • NASDAQ futures

    20,040.25
    +121.00 (+0.61%)
     

  • VOLATILITY

    12.59
    +0.11 (+0.88%)
     

  • FTSE

    8,239.77
    +34.66 (+0.42%)
     

  • NIKKEI 225

    38,633.02
    +62.26 (+0.16%)
     

  • CAD/EUR

    0.6797
    +0.0010 (+0.15%)
     

INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.

PR Newswire
·1 min read

PLYMOUTH MEETING, Pa., June 4, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that INOVIO's President and CEO, Dr. Jacqueline Shea, and Chief Medical Officer, Dr. Michael Sumner will participate in a virtual fireside chat hosted by Sudan Loganathan, Ph.D., Managing Director and equity research analyst at Stephens, Inc.

(PRNewsfoto/INOVIO Pharmaceuticals, Inc.)
(PRNewsfoto/INOVIO Pharmaceuticals, Inc.)

The fireside chat will take place on Tuesday, June 11, 2024, at 11:00am ET. This event is only available to institutional clients of Stephens. Please reach out to your Stephens contact for event details.

About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.

ADVERTISEMENT

Contacts
Media: Jennie Willson, (267) 429-8567, jennie.willson@inovio.com
Investors: Thomas Hong, (267) 440-4298, thomas.hong@inovio.com

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-participate-in-virtual-fireside-chat-hosted-by-stephens-inc-302162633.html

SOURCE INOVIO Pharmaceuticals, Inc.